Heightened response to e-cigarettes in COPD

Jack Bozier; Sandra Rutting; Dia Xenaki; Matthew Peters; Ian Adcock; Brian G Oliver

doi:10.1183/23120541.00192-2018

Heightened response to e-cigarettes in COPD

ERJ Open Res. 2019 Feb 26;5(1):00192-2018. doi: 10.1183/23120541.00192-2018. eCollection 2019 Feb.

Authors

Jack Bozier^{1

2}, Sandra Rutting¹, Dia Xenaki¹, Matthew Peters³, Ian Adcock^{4

5}, Brian G Oliver^{1

2}

Affiliations

¹ Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.
² School of Life Sciences, University of Technology Sydney, Sydney, Australia.
³ Concord Hospital, University of Sydney, Sydney, Australia.
⁴ Airway Diseases Section, National Heart and Lung Institute, Imperial College London, London, UK.
⁵ Biomedical Research Unit; Section of Respiratory Diseases, Royal Brompton and Harefield NHS Trust, London, UK.

Abstract

E-cigarettes induce greater inflammatory mediators from COPD lung cells; therefore, the risks of e-cigarette use in COPD might be greater than in people without COPD http://ow.ly/xmnN30nzDhX.